Beyond Degradation: How Reverse Proteolysis Creates Disease-Relevant Antigens

Abstract

Proteases are conventionally regarded as degradative enzymes, yet their catalytic machinery also permits peptide bond formation through reverse proteolysis, a process that remains poorly characterized. Here, we show that lysosomal cysteine cathepsins catalyze iterative cycles of hydrolysis and ligation to generate multi-generational fusion peptides, including hybrids derived from host-viral protein substrates. Quantitative analysis demonstrates that peptide ligation can account for up to 4.5% of proteolytic turnover. This activity is strongly influenced by pH, substrate sequence, and post-translational modification, with citrullination and neutral pH favoring fusion peptide formation and the accumulation of more stable higher-order products. Using full-length protein substrates, we provide direct evidence that cathepsins can generate a hybrid insulin peptide previously identified as a Type 1 Diabetes (TID) autoantigen in patients. Moreover, several identified fusion peptides show effective binding to TID-associated HLA class II molecules. To examine whether ligation products can be captured under cellular conditions, we developed a click-based targeted transpeptide retrieval and purification strategy (CT-TRAP), which enabled detection of probe-derived cis/transpeptides in cell-based systems under controlled conditions. These findings establish reverse proteolysis by cysteine cathepsins as a quantifiable enzymatic pathway for generating non-genomically templated peptides, revealing an unrecognized dimension of lysosomal protease activity and peptide diversification.